Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Apr 24, 2026 = ×
Apr 25, 2025 = ×
Apr 26, 2024 = ×
Apr 28, 2023 = ×
Apr 29, 2022 = ×
Apr 30, 2021 = ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The analysis of the two-component DuPont disaggregation reveals that the Return on Equity (ROE) has experienced notable volatility over the observed period, fluctuating between a low of 7.01% in 2021 and a peak of 9.71% in 2025 and 2026. The primary driver of these fluctuations is the Return on Assets (ROA), while financial leverage has remained relatively stable, exerting a secondary influence on the overall equity returns.

Return on Assets (ROA)
A non-linear trend is observed in asset productivity. ROA increased significantly from 3.87% in 2021 to a peak of 5.54% in 2022, before experiencing a contraction to 4.13% in 2023 and 4.09% in 2024. A recovery phase followed, with ROA rising to 5.09% in 2025 and further improving to 5.16% in 2026. This suggests that the company's ability to generate profits from its asset base is the dominant variable in the ROE equation.
Financial Leverage
The leverage ratio remained within a narrow band, ranging from 1.73 to 1.91. A slight deleveraging occurred in 2022, reaching a period low of 1.73. This was followed by a gradual increase over the subsequent years, peaking at 1.91 in 2025 before settling at 1.88 in 2026. The relative stability of this ratio indicates that the company has not relied heavily on increasing debt to amplify shareholder returns.
ROE Synthesis and Interaction
The interaction between the two components demonstrates that the ROE spike in 2022 was driven exclusively by operational efficiency (ROA), as this occurred despite a decrease in financial leverage. Conversely, the stabilization of ROE at 9.71% in 2025 and 2026 resulted from a combination of recovered asset productivity and a higher leverage multiplier. The close correlation between the movements of ROA and ROE confirms that profitability and asset utilization are the primary catalysts for equity performance.


Three-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Apr 24, 2026 = × ×
Apr 25, 2025 = × ×
Apr 26, 2024 = × ×
Apr 28, 2023 = × ×
Apr 29, 2022 = × ×
Apr 30, 2021 = × ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The Return on Equity (ROE) exhibits a fluctuating trend over the observed six-year period, characterized by a peak in 2022, a subsequent contraction, and a recovery to a plateau of 9.71% by 2025 and 2026. This performance is the result of varying interactions between profitability, asset efficiency, and financial leverage.

Net Profit Margin
Profitability demonstrates significant volatility, peaking at 15.90% in 2022 before declining to a period low of 11.36% in 2024. A recovery is observed in the final two years, with margins stabilizing between 13.20% and 13.90%. This component appears to be the primary driver of the overall ROE fluctuations.
Asset Turnover
A consistent upward trajectory is observed in asset utilization. The ratio increased steadily from 0.32 in 2021 to 0.39 in 2026. This gradual improvement indicates an increasing efficiency in generating revenue from the asset base, providing a stabilizing positive influence on the ROE despite the volatility in profit margins.
Financial Leverage
The leverage ratio remained relatively stable, fluctuating within a narrow range between 1.73 and 1.91. A slight increase in leverage is noted toward the end of the period, peaking at 1.91 in 2025, which marginally amplified the impact of the improving profit margins and asset turnover on the final equity return.
ROE Synthesis
The expansion of ROE to 9.71% in the final two years is attributed to a combined effect of recovered profit margins and the highest recorded levels of asset turnover. While financial leverage remained a constant multiplier, the underlying operational improvements in efficiency and profitability were the decisive factors in the upward trend observed from 2024 onward.


Five-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Apr 24, 2026 = × × × ×
Apr 25, 2025 = × × × ×
Apr 26, 2024 = × × × ×
Apr 28, 2023 = × × × ×
Apr 29, 2022 = × × × ×
Apr 30, 2021 = × × × ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The Return on Equity (ROE) exhibits a fluctuating but generally upward trajectory over the analyzed period, starting at 7.01% in 2021 and reaching a plateau of 9.71% by 2025 and 2026. This movement is the result of varying contributions from operational efficiency, tax impacts, and financial leverage.

Operational Profitability and Efficiency
The EBIT Margin showed an initial expansion from 15.92% in 2021 to a peak of 19.13% in 2023. Although a contraction to 17.08% occurred in 2024, the margin recovered and stabilized around 18.8% in the subsequent years. Complementing this, Asset Turnover demonstrates a consistent and steady improvement, rising from 0.32 in 2021 to 0.39 by 2026, indicating a progressive increase in the efficiency of asset utilization to generate revenue.
Tax and Interest Burdens
The Tax Burden experienced significant volatility, dropping sharply to a low of 0.70 in 2023, which acted as a primary drag on ROE during that period. A gradual recovery followed, with the ratio returning to 0.79 by 2026. The Interest Burden remained relatively stable, oscillating between 0.81 and 0.91, suggesting that interest expenses have been well-managed relative to operating profits.
Financial Leverage
Financial Leverage remained within a narrow range for much of the period, fluctuating between 1.73 and 1.81 before increasing to a peak of 1.91 in 2025. This uptick in leverage, combined with improved asset turnover and a recovering tax burden, contributed to the expansion of ROE in the final two years of the period.

Overall, the analysis indicates that while operational margins and tax fluctuations created short-term instability in equity returns, the long-term growth in ROE was supported by a steady increase in asset productivity and a strategic increase in financial leverage toward the end of the period.



Two-Component Disaggregation of ROA

Medtronic PLC, decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Apr 24, 2026 = ×
Apr 25, 2025 = ×
Apr 26, 2024 = ×
Apr 28, 2023 = ×
Apr 29, 2022 = ×
Apr 30, 2021 = ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The Return on Assets (ROA) exhibits a fluctuating trajectory over the analyzed six-year period, characterized by an initial peak in 2022, a subsequent mid-period decline, and a recovery toward the final two years. While the overall ROA increased from 3.87% in 2021 to 5.16% in 2026, the growth path was inconsistent, reflecting the interplay between profitability and asset efficiency.

Net Profit Margin
Profitability demonstrates significant volatility throughout the period. A sharp increase is observed between 2021 and 2022, where the margin peaked at 15.90%. This was followed by a downward trend, reaching a period low of 11.36% in 2024. A recovery occurred in 2025, reaching 13.90%, before settling slightly at 13.20% in 2026. These fluctuations suggest that ROA performance is heavily influenced by shifts in operational efficiency or pricing dynamics.
Asset Turnover
In contrast to profit margins, asset turnover shows a consistent and steady upward trend. The ratio improved from 0.32 in 2021 to 0.39 in 2026. This gradual increase indicates a systemic improvement in the ability to generate revenue from the asset base, providing a stabilizing effect on the overall return on assets.
ROA Disaggregation Synthesis
The two-component analysis reveals that the volatility in ROA is primarily driven by the Net Profit Margin rather than Asset Turnover. The peak ROA of 5.54% in 2022 was the direct result of a significant spike in profit margins. Conversely, the recovery of ROA to 5.16% by 2026 is the result of both a stabilized profit margin and a progressively stronger asset turnover ratio, suggesting a more balanced foundation for returns in the later years.


Four-Component Disaggregation of ROA

Medtronic PLC, decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Apr 24, 2026 = × × ×
Apr 25, 2025 = × × ×
Apr 26, 2024 = × × ×
Apr 28, 2023 = × × ×
Apr 29, 2022 = × × ×
Apr 30, 2021 = × × ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The Return on Assets (ROA) exhibits a general upward trajectory over the analyzed period, increasing from 3.87% in 2021 to 5.16% by 2026. This growth was interrupted by a mid-period contraction between 2022 and 2024, where ROA declined from 5.54% to 4.09% before recovering. The overall performance is driven by a combination of improving asset efficiency and fluctuating fiscal pressures.

Tax Burden
Significant volatility is observed in the tax burden, which experienced a sharp decline from 0.92 in 2022 to 0.70 in 2023. This contraction acted as a primary downward driver for ROA during the 2023-2024 period. While the ratio recovered to 0.83 by 2025, it concluded the period at 0.79, remaining lower than the levels recorded in 2021 and 2022.
Interest Burden
The interest burden remained relatively stable, indicating a consistent relationship between operating profit and net income. After an initial increase from 0.81 in 2021 to 0.91 in 2022, the ratio fluctuated within a narrow range between 0.87 and 0.90, suggesting that interest expenses have not been a primary driver of ROA volatility.
EBIT Margin
Operating profitability showed an initial expansion, rising from 15.92% in 2021 to a peak of 19.13% in 2023. A temporary dip to 17.08% occurred in 2024, followed by a recovery to 18.87% in 2025 and stabilization at 18.74% in 2026, maintaining a higher baseline than the start of the period.
Asset Turnover
A consistent and positive trend is evident in asset turnover, which grew steadily from 0.32 in 2021 to 0.39 in 2026. This represents the most stable component of the ROA disaggregation, reflecting a progressive improvement in the company's ability to generate revenue from its asset base.

The analysis indicates that while operational margins and asset efficiency have provided a strong foundation for growth, the overall return on assets has been periodically constrained by fluctuations in the tax burden. The recovery in ROA toward the end of the period is primarily attributable to the simultaneous improvement in asset turnover and a rebound in the tax burden ratio.



Disaggregation of Net Profit Margin

Medtronic PLC, decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Apr 24, 2026 = × ×
Apr 25, 2025 = × ×
Apr 26, 2024 = × ×
Apr 28, 2023 = × ×
Apr 29, 2022 = × ×
Apr 30, 2021 = × ×

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The Net Profit Margin demonstrates significant volatility over the analyzed period, peaking at 15.90% in 2022 before declining to a low of 11.36% in 2024 and partially recovering to 13.20% by 2026. A disaggregation of this margin reveals that the fluctuations in bottom-line profitability are not primarily driven by operational performance, but rather by fluctuations in the tax burden.

Operating Efficiency (EBIT Margin)
The EBIT margin shows a general upward trajectory from 15.92% in 2021 to a peak of 19.13% in 2023. Although a contraction occurred in 2024 (17.08%), the margin recovered and stabilized near 18.8% in the subsequent two years. This indicates that the core operational profitability of the business remained relatively resilient and stronger than the overall net profit margin throughout the period.
Debt Impact (Interest Burden)
The interest burden remained the most stable component of the margin disaggregation. After an initial increase from 0.81 in 2021 to 0.91 in 2022, the ratio fluctuated minimally between 0.87 and 0.90. This stability suggests that interest expenses have not been a primary driver of the volatility observed in the net profit margin.
Tax Impact (Tax Burden)
The tax burden exhibits the highest level of volatility and serves as the primary detractor from net profitability. A sharp decline is observed in 2023, where the ratio dropped to 0.70 from 0.92 in 2022. This specific decline explains the divergence seen in 2023, where the EBIT margin reached its peak (19.13%) while the net profit margin fell sharply to 12.03%. The ratio showed a gradual recovery toward 0.83 in 2025 before settling at 0.79 in 2026.

In summary, the analysis indicates a decoupling between operational success and net earnings. The stability of the interest burden and the strength of the EBIT margin suggest that the decline in net profit margins between 2022 and 2024 was predominantly caused by a deteriorating tax burden ratio rather than a failure in operational execution or increased debt servicing costs.